Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about newspaper publication

27 May 2024 Evaluate
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has enclosed copies of newspaper advertisement of the financial results of the company for the fourth quarter and financial year ended March 31, 2024, as published in Business Standard and Nava Telangana on May 27, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..